14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
AMD vs XHS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over SPDR S&P Health Care Services ETF (XHS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMD carries a Unified Composite Score of 48.7/100 (HOLD) at $505.31 (30.2x Forward P/E, 17.8% operating margin), whereas XHS carries 45.3/100 (HOLD) at $146.16 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMD vs XHS. Trailing 12-month operating profitability (AMD 17.8% vs XHS N/A) and valuation multiples (AMD 30.2x vs XHS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ AMD vs XHS Key Questions & Quantitative Answers
As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over SPDR S&P Health Care Services ETF (XHS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMD carries a Unified Composite Score of 48.7/100 (HOLD) at $505.31 (30.2x Forward P/E, 17.8% operating margin), whereas XHS carries 45.3/100 (HOLD) at $146.16 (N/M Forward P/E, N/A operating margin). Technically, AMD sits in a Neutral phase (RSI 47.2, CONSOLIDATION options structure) and XHS sits in a Markup phase (RSI 57.7, UNCLASSIFIED options structure).
AMD leads the Growth & Scale pillar: AMD posts +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin), compared with XHS at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, AMD generates $45.4B in USD-normalized revenue versus N/A for XHS. In operating R&D and SG&A reinvestment, AMD deploys 38.2% of Rev ($17.4B) (7 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XHS.
AMD screens cheaper on headline valuation multiples. AMD trades at 30.2x Forward P/E, 125.1x Trailing P/E, 0.50x PEG, and 21.2x EV/Revenue (15.5% FCF margin), whereas XHS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMD (12.0% ROE) versus XHS (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, AMD carries 78.1% implied volatility (10th %ile, Compressed (<25th %ile)), a 1.07x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (3.59β · 118% Vol realized risk). By comparison, XHS carries 111.4% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.46β · 26% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.